Prof. Robert Bristow MD PhD FRCPC studies in the Division of Cancer Sciences at the University of Manchester. In addition, Robert is also Research Domain Director for Cancer and Chief Academic Officer at the Christie NHS Foundation Trust.
He came to Manchester in 2017 from Toronto (Canada), where he was a clinician-scientist and professor with appointments within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto and a senior scientist at the Princess Margaret Centre.
His primary research interests are DNA damage responses and repair in tumours, tumour hypoxia, prostate cancer carcinogenesis and prostate cancer treatment. He is particularly interested in novel clinical trials that intensify cancer therapy to prostate cancer patients whose tumours harbour aggressive genetic changes and hypoxic sub-regions.
Prof Bristow is Editor of the 5th Edition Basic Science of Oncology and has over 250 published papers and book chapters. He is twice a Canadian Foundation for Innovation (CFI) awardee and he was made a Canadian Cancer Society Research Scientist in 2004 and an ESTRO Honorary Fellow in 2011.